CTXR
NASDAQ · Pharmaceuticals
Citius Pharmaceuticals Inc
$0.71
-0.04 (-5.48%)
Open$0.74
Previous Close$0.75
Day High$0.75
Day Low$0.68
52W High$2.48
52W Low$0.63
Volume—
Avg Volume936.0K
Market Cap17.24M
P/E Ratio—
EPS$-2.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+442.3% upside
Current
$0.71
$0.71
Target
$3.85
$3.85
$3.27
$3.85 avg
$6.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.36M | 3.56M | 3.14M |
| Net Income | 635.6K | 690.8K | 743.5K |
| Profit Margin | 18.9% | 19.4% | 23.7% |
| EBITDA | 1.24M | 1.20M | 1.26M |
| Free Cash Flow | 627.5K | 529.6K | 500.9K |
| Rev Growth | -2.5% | +1.7% | -0.7% |
| Debt/Equity | 1.45 | 1.39 | 1.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |